Magazine Article | June 1, 2021

How To Identify Capital To Fund Life Sciences Growth

Source: Life Science Leader

By Peter Meath

The challenges created by the global COVID-19 pandemic have cast a spotlight on the life sciences industry and the lifesaving solutions that it can provide. We’re seeing an acceleration of interest in the space and a significant increase in resources, investments, and alternative sources of capital.

In the first half of 2020, life sciences companies secured 44 supergiant funding rounds of $100 million or more — a record number. During the year, investors globally put $16.55 billion to work across 450 deals in the biotech and life sciences sectors at Series A and beyond. That’s up considerably from 2019, when investors put $13.4 billion to work across nearly 600 known funding rounds.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: